EWA
MBOT icon

EverSource Wealth Advisors’s Microbot Medical MBOT Stock Holding History

EverSource Wealth Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$860 Hold
357
– – ﹤0.01% 3905
2025
Q4 		$714 Hold
357
– – ﹤0.01% 3792
2025
Q3 		$1.09K Hold
357
– – ﹤0.01% 3738
2025
Q2 		$900 Hold
357
– – ﹤0.01% 3763
2025
Q1 		$539 Buy
+357
New +$631 ﹤0.01% 3433

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

EverSource Wealth Advisors's MBOT Position: Q1 2026 in Review

EverSource Wealth Advisors held its Microbot Medical (MBOT) position steady in Q1 2026 at 357 shares worth $860. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

EverSource Wealth Advisors first reported a position in MBOT in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.09K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • EverSource Wealth Advisors held 357 shares of Microbot Medical worth $860 as of Q1 2026.
  • EverSource Wealth Advisors left its Microbot Medical share count unchanged in Q1 2026.
  • Microbot Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3905 holding.
  • EverSource Wealth Advisors first reported a position in Microbot Medical in Q1 2025 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's Microbot Medical position peaked at $1.09K in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.